» Articles » PMID: 27743906

Validation of Highly Sensitive Simultaneous Targeted and Untargeted Analysis of Keto-steroids by Girard P Derivatization and Stable Isotope Dilution-liquid Chromatography-high Resolution Mass Spectrometry

Overview
Journal Steroids
Publisher Elsevier
Specialty Biochemistry
Date 2016 Nov 5
PMID 27743906
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

A multiplexed quantitative method for the analysis of three major unconjugated steroids in human serum by stable isotope dilution liquid chromatography-high resolution mass spectrometry (LC-HRMS) was developed and validated on a Q Exactive Plus hybrid quadrupole/Orbitrap mass spectrometer. This quantification utilized isotope dilution and Girard P derivatization on the keto-groups of testosterone (T), androstenedione (AD) and dehydroepiandrosterone (DHEA) to improve ionization efficiency using electrospray ionization. Major isomeric compounds to T and DHEA; the inactive epimer of testosterone (epiT), and the metabolite of AD, 5α-androstanedione (5α-AD) were completely resolved on a biphenyl column within an 18min method. Inter- and intra-day method validation using LC-HRMS with qualifying product ions was performed and acceptable analytical performance was achieved. The method was further validated by comparing steroid levels from 100μL of serum from young vs older subjects. Since this approach provides high-dimensional HRMS data, untargeted analysis by age group was performed. DHEA and T were detected among the top analytes most significantly different across the two groups after untargeted LC-HRMS analysis, as well as a number of other still unknown metabolites, indicating the potential for combined targeted/untargeted analysis in steroid analysis.

Citing Articles

Characterization of spironolactone and metabolites derivatized using Girard's reagent P using mass spectrometry and ion mobility spectrometry.

Jones S, Kirkwood-Donelson K, Alexander G, Perera L, Dudek S, Jarmusch A Rapid Commun Mass Spectrom. 2024; 38(15):e9775.

PMID: 38807480 PMC: 11391855. DOI: 10.1002/rcm.9775.


High sensitivity LC-MS methods for quantitation of hydroxy- and keto-androgens.

Detlefsen A, Paulukinas R, Mesaros C Methods Enzymol. 2023; 689:355-376.

PMID: 37802578 PMC: 11624892. DOI: 10.1016/bs.mie.2023.04.009.


Maternal androgens and autism spectrum disorder in the MARBLES prospective cohort study.

Granillo L, Iosif A, Goodrich A, Snyder N, Schmidt R Res Autism Spectr Disord. 2023; 99.

PMID: 36938498 PMC: 10022653. DOI: 10.1016/j.rasd.2022.102054.


Conversion of Classical and 11-Oxygenated Androgens by Insulin-Induced AKR1C3 in a Model of Human PCOS Adipocytes.

Paulukinas R, Mesaros C, Penning T Endocrinology. 2022; 163(7).

PMID: 35560164 PMC: 9162389. DOI: 10.1210/endocr/bqac068.


Progress and Challenges in Quantifying Carbonyl-Metabolomic Phenomes with LC-MS/MS.

Sun Y, Tang H, Wang Y Molecules. 2021; 26(20).

PMID: 34684729 PMC: 8541004. DOI: 10.3390/molecules26206147.


References
1.
Tai S, Xu B, Welch M, Phinney K . Development and evaluation of a candidate reference measurement procedure for the determination of testosterone in human serum using isotope dilution liquid chromatography/tandem mass spectrometry. Anal Bioanal Chem. 2007; 388(5-6):1087-94. DOI: 10.1007/s00216-007-1355-3. View

2.
Xia J, Sinelnikov I, Han B, Wishart D . MetaboAnalyst 3.0--making metabolomics more meaningful. Nucleic Acids Res. 2015; 43(W1):W251-7. PMC: 4489235. DOI: 10.1093/nar/gkv380. View

3.
Niwa M, Watanabe M, Watanabe N . Chemical derivatization in LC-MS bioanalysis: current & future challenges. Bioanalysis. 2015; 7(19):2443-9. DOI: 10.4155/bio.15.177. View

4.
Yasuda K . SYNTHESIS OF 2-ALPHA-HALO-4-EN-3-OXO-STEROIDS. Chem Pharm Bull (Tokyo). 1964; 12:1217-24. DOI: 10.1248/cpb.12.1217. View

5.
Rossi C, Calton L, Hammond G, Brown H, Michael Wallace A, Sacchetta P . Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry. Clin Chim Acta. 2009; 411(3-4):222-8. DOI: 10.1016/j.cca.2009.11.007. View